Rhythm Expands ColoSTAT Clinical Trial To Tenth Site
Filed with ASX · · 2 pages · English
® ® ® ® Clinical Trial (Study 7). ColoSTAT is aimed to be a globally marketed, low-cost, simple blood test for the early detection of colorectal cancer for mass-market screening. Sunshine Coast University Hospital is located 9km north of Caloundra and is the first trial site in Queensland. The hospital is a major provider of public health services and research in the Sunshine Coast, Gympie and Noo
Rhythm Biosciences Limited on 6ix
Story so far
Earlier from Rhythm Biosciences
- Initial Manufacturing of ColoSTAT Test-Kits Complete
- Rhythm Advances ColoSTAT Study 7
- Investor Presentation - December 2020
- Rhythm Secures US Patent - Strengthens Global Footprint
- Rhythm Appoints Global Manufacturer for ColoSTAT
Later from Rhythm Biosciences
- Study 6 Successfully Concluded - Exceptional Results
- Rhythm Retains ISO13485 Certification
- Rhythm Extends ColoSTAT Clinical Trial to Western Australia
- Rhythm Betters ColoSTAT Results
- FY22 Strategic Update
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences